The ImmunArray Story
Founded in 2006 based on iCHIP® technology licensed from the Weizmann Institute of Science, Immunarray has grown into a global company with offices and facilities close to its scientific roots in Rehovot, Israel and as part of the growing life sciences sector in Richmond, Virginia.
The company is dedicated to helping physicians manage complex autoimmune and neurologic diseases, including traumatic brain injury, by providing them with information from proprietary multi-analyte biomarker-based tests. To this end, the company conducts research and develops products in collaboration with leading investigators, advisors, clinicians, partners and medical centers in the USA, Europe and Israel.
ImmunArray provides commercial testing to rule out a diagnosis of Systemic Lupus Erythematosus from its CLIA compliant lab in Richmond, VA and is developing additional products for disease diagnosis and monitoring. In the case of traumatic brain injury, products are being developed for both the acute setting and to monitor the emergence and resolution of chronic sequelae following TBI.
ImmunArray Ltd. holds an exclusive, worldwide license from the Weizmann Institute of Science for the iCHIP® technology and also has worldwide exclusive licenses from Johns Hopkins University in the field of brain injury, Brigham and Women’s in Multiple Sclerosis and a growing body of company filed patents.